Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by moonball32on Jan 21, 2021 5:56pm
149 Views
Post# 32355363

RE:RE:As THRM is alone in this field and has a functional test it

RE:RE:As THRM is alone in this field and has a functional test it So I looked into your post and there are some holes in it. 1. Test specificity are almost identical 86% thrm vs 90% qgen 2. Qgen is a swab based test with the need for a smartphone to use their test technology 3. Their test price is set at $30.00 USD per test, very pricey for a disposable test. 4. Yes it was approved by FDA in December 2020, however they pulled back their product due to chemical issues with the test 5. They are re-doing their test sample of 198 persons and hope to have their product resubmitted by sometime in Q1 2021 to FDA as per news release Jan 20, 2021 6. No indication of a HC or EU submission. 7. Thrm will be a rapid Saliva NOT swab test and more economically priced. So still saying big business will not have any interest in this company ?? Your fear mongering needs a little more work buddy.
<< Previous
Bullboard Posts
Next >>